| Application no. and date | 09711944.0 (espacenet) (Federated) (European Patent Register), 20090220 | | Patent/reg. no. and date | DK/EP 2252300, 20161019 | | Publication date | 20101124 | | Priority no. and date | US 30903, 20080222 | | EP pub. no. and date |
EP 2252300 20101124 | | Effective date | | | Applicant/owner | Rigel Pharmaceuticals, Inc., 1180 Veterans Boulevard
South San Francisco, CA 94080, US | | Applicant ref. no. | RIGEL 242.01 | | Inventor | MASUDA, Esteban, 232 Oakhurst Place
Menlo Park
California 94025, US,
SCHMITZ, Jochen, 7030 Central Avenue
Indianapolis, Indiana 46220, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/5383 (2006.01) , A61K 31/662 (2006.01) , A61P 9/10 (2006.01) | | Title | ANVENDELSE AF 2,4-PYRIMIDINDIAMINER TIL BEHANDLING AF ATEROSKLEROSE | | Int. application no. | US2009034718 | | Int. publication no. | WO2009105675 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
